Advocacy Wealth Management Services’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Advocacy Wealth Management Services’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-100	Closed	-$6K	–	222
2017 Q4	$6K	Hold	100	–	–	﹤0.01%	185
2017 Q3	$6K	Hold	100	–	–	﹤0.01%	231
2017 Q2	$12K	Hold	100	–	–	﹤0.01%	174
2017 Q1	$11K	Hold	100	–	–	﹤0.01%	199
2016 Q4	$11K	Hold	100	–	–	﹤0.01%	191
2016 Q3	$16K	Hold	100	–	–	0.01%	235
2016 Q2	$14K	Hold	100	–	–	0.01%	277
2016 Q1	$13K	Hold	100	–	–	0.01%	331
2015 Q4	$15K	Buy	+100	New	+$16.9K	0.02%	305

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Advocacy Wealth Management Services's ICPT Position: Q1 2018 in Review

Advocacy Wealth Management Services sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2018, closing a stake of 100 shares — an estimated $6K sold.

Advocacy Wealth Management Services first reported a position in ICPT in Q4 2015 and held it in 9 quarters. The position peaked at $16K in Q3 2016. 147 funds tracked by Wall St. Rank hold ICPT as of Q1 2018.

Advocacy Wealth Management Services reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Advocacy Wealth Management Services sold 100 Intercept Pharmaceuticals, Inc. shares in Q1 2018, an estimated $6K.
Advocacy Wealth Management Services first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2015 and held it in 9 quarters.
Advocacy Wealth Management Services's Intercept Pharmaceuticals, Inc. position peaked at $16K in Q3 2016.
147 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2018.

Based on Advocacy Wealth Management Services's 13F filing for Q1 2018, filed 12 Apr 2018.